Summit Securities Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-183
Closed -$5.55K 1055
2025
Q1
$5.55K Buy
+183
New +$6.97K ﹤0.01% 599
2017
Q3
Sell
-5,026
Closed -$248K 201
2017
Q2
$248K Buy
+5,026
New +$223K 0.04% 169
2016
Q4
Sell
-5,817
Closed -$288K 263
2016
Q3
$288K Sell
5,817
-7,683
-57% -$400K 0.1% 102
2016
Q2
$748K Buy
13,500
+9,129
+209% +$534K 0.4% 54
2016
Q1
$241K Buy
+4,371
New +$249K 0.17% 116

Other funds holding ACHC

Summit Securities Group's ACHC Position: Q2 2025 in Review

Summit Securities Group sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 183 shares — an estimated $5.55K sold.

Summit Securities Group first reported a position in ACHC in Q1 2016 and held it in 5 quarters. The position peaked at $748K in Q2 2016. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

  • Summit Securities Group reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
  • Summit Securities Group sold 183 Acadia Healthcare shares in Q2 2025, an estimated $5.55K.
  • Summit Securities Group first reported a position in Acadia Healthcare in Q1 2016 and held it in 5 quarters.
  • Summit Securities Group's Acadia Healthcare position peaked at $748K in Q2 2016.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.